DB FOOT PAIN RELIEVING- apis mellifica, gelsemium sempervirens, gnaphalium spray 
The Magni Group Inc

Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

----------

Active Ingredients (In Spray) - Purpose
Apis Mellifica 3X HPUS - Relieves Foot Pain
Gnaphalium 3X HPUS - Relieves Foot Pain
Gelsemium Sempervirens 6X HPUS - External Analgesic

Pain Relieving Foot Spray DB

NDC: 43689-0039

Purpose:
Relieves Foot Pain
External Analgesic

NDC: 43689-0039

Use:
Temporarily Relieves Foot Pain

NDC: 43689-0039

Keep out of reach of children

NDC: 43689-0039

Warnings:
For external use only

NDC: 43689-0039

When using this product:
- Avoid contact with eyes

NDC: 43689-0039

If symptoms persist for more than 7 days or worsen,
consult your physician

NDC: 43689-0039

Do not use on open wounds, cuts, damaged, or
infected skin

NDC: 43689-0039

Directions:
- Adults and children 12 years of age and older, apply to all surfaces on the feet, heels and toes up to four times daily
- Apply to legs as needed

NDC: 43689-0039

Other information:
- Most beneficial when applied after bathing, showering, or a foot soak
- The letters "HPUS" indicate that the components in this product are officially monographed in the Homeopathic Pharmacopeia of the United States
- These statements are supported by the traditional homeopathic principles

NDC: 43689-0039

Inactive Ingredients:
Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Benzoic Acid, Bergamot Oil, C14-22 Alcohol/C12-20 Alkyl Glucoside, Canola Oil, Camphor Gum, Citric Acid, Ethylhexyl Stearate, Eucalyptus Oil, Glycerin, Mentha Piperita (Peppermint) Extract, Menthol, Methyl Salicylate, Panthenol, Phenoxyethanol, Sodium Hydroxide, Sorbic Acid, Tocopheryl Acetate, Water (Aqua), Xanthan Gum

NDC: 43689-0039

Principal Display Panel

Principal Display Panel DB

NDC: 43689-0039

DB FOOT PAIN RELIEVING 
apis mellifica, gelsemium sempervirens, gnaphalium spray
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:43689-0039
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PSEUDOGNAPHALIUM LUTEOALBUM LEAF (UNII: BGI20Z6M57) (PSEUDOGNAPHALIUM LUTEOALBUM LEAF - UNII:BGI20Z6M57) PSEUDOGNAPHALIUM LUTEOALBUM LEAF3 [hp_X]  in 100 g
APIS MELLIFERA (UNII: 7S82P3R43Z) (APIS MELLIFERA - UNII:7S82P3R43Z) APIS MELLIFERA3 [hp_X]  in 100 g
GELSEMIUM SEMPERVIRENS ROOT (UNII: 639KR60Q1Q) (GELSEMIUM SEMPERVIRENS ROOT - UNII:639KR60Q1Q) GELSEMIUM SEMPERVIRENS ROOT6 [hp_X]  in 100 g
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
C12-20 ALKYL GLUCOSIDE (UNII: K67N5Z1RUA)  
CANOLA OIL (UNII: 331KBJ17RK)  
ETHYLHEXYL STEARATE (UNII: EG3PA2K3K5)  
METHYL SALICYLATE (UNII: LAV5U5022Y)  
SORBIC ACID (UNII: X045WJ989B)  
MENTHOL (UNII: L7T10EIP3A)  
CAMPHOR (SYNTHETIC) (UNII: 5TJD82A1ET)  
PANTHENOL (UNII: WV9CM0O67Z)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
C14-22 ALCOHOLS (UNII: B1K89384RJ)  
MENTHA X PIPERITA WHOLE (UNII: 79M2M2UDA9)  
BERGAMOT OIL (UNII: 39W1PKE3JI)  
GLYCERIN (UNII: PDC6A3C0OX)  
EUCALYPTUS OIL (UNII: 2R04ONI662)  
XANTHAN GUM (UNII: TTV12P4NEE)  
CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: 809Y72KV36)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
BENZOIC ACID (UNII: 8SKN0B0MIM)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:43689-0039-185 g in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product12/29/2020
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved homeopathic12/29/2020
Labeler - The Magni Group Inc (113501902)
Establishment
NameAddressID/FEIBusiness Operations
United Laboratories Manufacturing LLC807878116manufacture(43689-0039)

Revised: 12/2020
Document Id: b06c4a3e-2c6a-3a9c-e053-2a95a90a4fb8
Set id: b06c4a3e-2c69-3a9c-e053-2a95a90a4fb8
Version: 1
Effective Time: 20201229
 
The Magni Group Inc